Zenas BioPharma Balance Sheet (2023-2026) | ZBIO

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter) 72.31M56.86M37.15M183.93M360.04M319.74M196.55M44.01M115.56M110.64M500.22M
Short-term Investments (Quarter) 0.09M0.09M0.09M31.02M115.83M229.27M175.32M232.55M216.98M
Cash & Current Investments (Quarter) 72.31M56.86M37.24M184.02M360.13M350.77M312.38M273.28M290.88M343.19M717.21M
Prepaid Assets (Quarter) 2.95M6.98M5.07M5.43M5.32M5.76M7.98M12.96M
Current Assets (Quarter) 59.80M393.78M355.92M317.81M278.60M296.64M351.17M730.16M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 0.19M0.15M0.18M0.07M0.06M0.05M0.03M0.03M
Long-Term Investments (Quarter) 1.83M1.61M10.72M17.27M1.34M
Other Non-Current Assets (Quarter) 0.09M5.79M12.64M0.21M11.80M13.80M0.22M15.06M
Non-Current Assets (Quarter) 8.38M9.65M14.04M15.96M14.48M25.38M32.47M17.52M
Assets (Quarter) 68.18M403.43M369.97M333.77M293.08M322.02M383.64M747.68M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 5.40M15.08M17.14M20.02M7.93M6.44M7.11M8.94M
Payables (Quarter) 5.40M15.08M17.14M20.02M7.93M6.44M7.11M8.94M
Accumulated Expenses (Quarter) 17.31M28.53M39.37M28.21M6.05M8.76M13.08M5.62M
Other Accumulated Expenses (Quarter) 0.11M0.33M0.25M0.38M0.51M0.58M0.87M0.94M
Current Leases (Quarter) 0.56M0.38M0.79M0.91M0.79M0.62M1.11M1.04M
Current Taxes (Quarter) 0.30M0.21M0.01M0.12M0.12M
Total Current Liabilities (Quarter) 23.26M44.00M57.29M49.13M53.24M52.42M62.65M61.16M
Non-Current Liabilities
Non-Current Debt (Quarter) 72.99M78.64M72.08M
Convertible Debt (Quarter) 20.30M
Preferred Stock Liabilities (Quarter) 55.84M250.09M55.84M55.84M
Operating Leases (Quarter) 0.26M0.22M0.32M0.21M0.18M0.21M0.08M
Other Non-Current Liabilities (Quarter) 20.30M78.64M84.90M
Total Non-Current Liabilities (Quarter) 23.52M0.22M73.17M78.85M350.69M
Total Liabilities (Quarter) 202.23M43.81M252.50M288.78M44.00M57.51M49.45M53.46M125.59M141.50M411.85M
Shareholder's Equity
Total Debt (Quarter) 72.99M78.64M72.08M
Common Equity (Quarter) -202.23M-225.72M-252.50M-288.78M359.44M312.46M284.32M239.63M196.43M242.14M335.83M
Shareholder's Equity (Quarter) -202.23M-225.72M-252.50M-288.78M359.44M312.46M284.32M239.63M196.43M242.14M335.83M
Liabilities and Shareholders Equity (Quarter) 68.18M403.43M369.97M333.77M293.08M322.02M383.64M747.68M
Retained Earnings (Quarter) -230.40M-334.79M0.19M0.14M-473.19M-524.70M-0.06M-846.12M
Treasury Shares (Quarter) 0.03M0.02M0.02M0.51M0.53M0.60M0.67M